10th Annual Oligo Networking Event

Continuing Excellence in Oligo Discovery & Development - Maximising Healthcare Outcomes

Developed by the community for the community

Tuesday 28 - Wednesday 29 March 2023

Novartis, in partnership with Cytiva, GSK, Roche, AstraZeneca, Janssen, BioMax, Ionis and Biogen are pleased to invite you to their 10th oligonucleotide networking event. The title of this year's event is "Continuing Excellence in Oligo Development - Maximising Healthcare Benefits"

This two-day hybrid meeting is kindly being hosted by Novartis in Basel, Switzerland and online for those who wish to attend virtually. The meeting is free to attend

The themes covered in the 2023 meeting will include:

Review of the last 10 years, and looking forward to the next
Manufacturing Technologies
Analysing oligos
Alternative drug delivery mechanisms
Patient perspective

The meeting aims to bring together the community of interested professionals and practitioners in industry and academia to network virtually, discuss the latest developments in this field, explore knowledge transfer issues and share best practise.

Novartis

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis' purpose is to reimagine medicine to improve and extend people's lives, using innovative science and technology to address some of society's most challenging healthcare issues. They discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. They also aim to reward those who invest their money, time and ideas in their company.